Pages that link to "Q42837390"
Jump to navigation
Jump to search
The following pages link to Early Steroid-Free Immunosuppression With FK506 After Liver Transplantation: Long-Term Results of a Prospectively Randomized Double-Blinded Trial (Q42837390):
Displaying 27 items.
- Glucocorticosteroid-free versus glucocorticosteroid-containing immunosuppression for liver transplanted patients (Q24187112) (← links)
- Steroid sparing protocols following nonrenal transplants; the evidence is not there. A systematic review and meta-analysis (Q26864103) (← links)
- Everolimus in clinical practice in long-term liver transplantation: an observational study (Q33396703) (← links)
- Reduced fibrosis in recurrent HCV with tacrolimus, azathioprine and steroids versus tacrolimus: randomised trial long term outcomes. (Q33659942) (← links)
- Corticosteroid-free immunosuppression in liver transplantation: an evidence-based review (Q34067842) (← links)
- Post-liver transplant hepatitis C virus recurrence: an unresolved thorny problem (Q34093760) (← links)
- Efficacy of immunosuppression monotherapy after liver transplantation: a meta-analysis (Q35260470) (← links)
- Analysis of adult 20-year survivors after liver transplantation (Q35757871) (← links)
- Posttransplant metabolic syndrome (Q36446760) (← links)
- Minimizing tacrolimus decreases the risk of new-onset diabetes mellitus after liver transplantation (Q36501716) (← links)
- Evolving concepts in the selection of immunosuppression regimen for liver transplant recipients (Q37355472) (← links)
- Role of steroid minimization in the tacrolimus-based immunosuppressive regimen for liver transplant recipients: a systematic review and meta-analysis of prospective randomized controlled trials (Q37709229) (← links)
- Metabolic syndrome: Is immunosuppression to blame? (Q37901443) (← links)
- Medical Management of the Liver Transplant Recipient (Q37950064) (← links)
- Immunosuppression, liver injury and post‐transplant HCV recurrence (Q37970381) (← links)
- Tacrolimus trough levels, rejection and renal impairment in liver transplantation: a systematic review and meta-analysis. (Q38019054) (← links)
- Review article: use of induction therapy in liver transplantation (Q38032009) (← links)
- Clinical pharmacokinetics and pharmacodynamics of prednisolone and prednisone in solid organ transplantation (Q38047203) (← links)
- Induction immunosuppression in liver transplantation: a review (Q38104751) (← links)
- Current strategies for immunosuppression following liver transplantation (Q38205739) (← links)
- Hepatocellular carcinoma: current management and future development-improved outcomes with surgical resection (Q38368606) (← links)
- Maintenance immunosuppression for adults undergoing liver transplantation: a network meta-analysis. (Q38737314) (← links)
- Liver Transplantation: the Role of Metabolic Syndrome (Q39255762) (← links)
- Duplicate publication bias weakens the validity of meta-analysis of immunosuppression after transplantation (Q43171519) (← links)
- Impact of the Conversion of the Immunosuppressive Regimen from Prograf to Advagraf or to Sirolimus in Long-term Stable Liver Transplant Recipients: Indications, Safety, and Outcome (Q44623798) (← links)
- Glucocorticosteroid-free versus glucocorticosteroid-containing immunosuppression for liver transplanted patients. (Q53279063) (← links)
- Recurrence of Hepatitis B Infection in Liver Transplant Patients Receiving Long-Term Hepatitis B Immunoglobulin Prophylaxis (Q59328853) (← links)